Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 368-371

  Mordan McCombs, Sarah ^a,b   Brown, Theodore ^b   Wang, Wei Lin Winnie ^a   Gaupel, Ann Christin ^a   Welsh, JoEllen ^a   Tenniswood, Martin ^a  

^a UNIVERSITY AT ALBANY   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Androgen; Prostrate cancer; Vitamin D

Indexed keywords

ANDROGEN RECEPTOR; CYCLIN DEPENDENT KINASE 2; CYCLINE; MESSENGER RNA; SOMATOMEDIN C RECEPTOR; SURVIVIN; TESTOSTERONE; VITAMIN D; VITAMIN D RECEPTOR; ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, MOUSE; CALCIFEDIOL; CALCITRIOL RECEPTOR; CDK2 PROTEIN, MOUSE; INHIBITOR OF APOPTOSIS PROTEIN; REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; KNOCKOUT MOUSE; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROSTATE CANCER; STEADY STATE; SUPPLEMENTATION; TESTOSTERONE BLOOD LEVEL; TRANSGENIC MOUSE; TUMOR GROWTH; WILD TYPE; ANIMAL; APOPTOSIS; BLOOD; DISEASE COURSE; HUMAN; METABOLISM; PROSTATIC NEOPLASMS;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIFEDIOL; CYCLIN-DEPENDENT KINASE 2; DISEASE PROGRESSION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MICE; MICE, TRANSGENIC; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATIC NEOPLASMS; RECEPTOR, IGF TYPE 1; RECEPTORS, ANDROGEN; RECEPTORS, CALCITRIOL; REPRESSOR PROTEINS; TESTOSTERONE;

MUS;

EID: 77954763192     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.062     Document Type: Article

References (18)

1. 1 accumulation. Endocrinology 1998, 139:1197-1207.
2. 3 on primary cultures of human prostatic cells. Cancer Res. 1994, 54:805-810.
3. Murthy S., Agoulnik I.U., Weigel N.L. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Prostate 2005, 64:362-372.
4. L.P.Freedman L.P. Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation. J. Nutr. 1999, 129(1999):581S-586S.
5. Yang E.S., Burnstein K.L. Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 2003, 278:46864-46868.
6. Blutt S.E., Polek T.C., Stewart L.V., Kattan M.W., Weigel N.L. A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res. 2000, 60(2000):779-782.
7. Platz E.A., Leitzmann M.F., Hollis B.W., Willett W.C., Giovannucci E. Plasma 1,25-dihydroxy-and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 2004, 15:255-265.
8. Damber J.-E., Aus G. Prostate cancer. Lancet 2008, 371:1710-1721.
9. 3 is an active hormone in human primary prostatic stromal cells. FASEB J. 2004, 18:332-334.
10. 3 receptor (VDR) expression in human prostate. J. Steroid Biochem. Mol. Biol. 1998, 66(1998):121-127.
11. Kasper S., Sheppard P.C., Yan Y., Pettigrew N., Borowsky A.D., Prins G.S., Dodd J.G., Duckworth M.L., Matusik R.J. Development, progression and androgen-dependence of prostate tumors in probasin-large T-antigen transgenic mice: a model for prostate cancer. Lab. Invest. 1998, 78:319-333.
12. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., Demay M.B. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:9831-9835.
13. Mordan-McCombs S., Brown T., Welsh J., Tenniswood M. Dietary calcium does not affect prostate tumor progression in LPB-Tag transgenic mice. J. Steroid Biochem. Mol. Biol. 2007, 103:747-751.
14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
15. Leman E.S., Arlotti J.A., Dhir R., Getzenberg R. Vitamin D and androgen regulation of prostatic growth. J. Cell. Biochem. 2003, 90:138-147.
16. Bao B.-Y., Hu Y.-C., Ting H.-J., Lee Y.-F. Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells. Oncogene 2004, 23:3350-3360.
17. Cano P., Godoy A., Escamilla R., Dhir R., Onate S.A. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer. Cancer Res. 2007, 511-519.
18. Hidalgo A.A., Paredes R., Garcia V.M., Flynn G., Johnson C.S., Trump D.L., Onate S.A. Altered VDR-mediated transcriptional activity in prostate cancer stroma. J. Steroid Biochem. Mol. Biol. 2007, 103:731-736.